Journal of Clinical Virology
Volume 29, Issue 3 , Pages 167-170 , March 2004

Laboratory-acquired vaccinia infection

  • Clifford G. Wlodaver

      Affiliations

    • 3400 N.W. Expressway, Suite 410, Oklahoma City, OK 73112, USA
    • ,
  • Gregory J. Palumbo

      Affiliations

    • Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
    • ,
  • Joseph L. Waner

      Affiliations

    • Department of Pediatrics, University of Oklahoma Health Sciences Center, Children's Hospital of Oklahoma, 940 N.E. 13th Street, Oklahoma City, OK 73190, USA
    • Corresponding Author InformationCorresponding author. Address: Department of Pediatrics, Children's Hospital of Oklahoma, 940 N.E. 13th Street, Oklahoma City, OK 73104, USA. Tel.: +1-405-271-3567; fax: +1-405-271-8651.

Received 8 January 2003 ,Revised 14 April 2003 ,Accepted 21 April 2003.

References 

  1. Binns MM, Smith GL. In: Recombinant poxviruses. Boca Raton, FL: CRC Press; 1992;p. 235–267
  2. Buller RML, Palumbo GJ. Safety and attenuation of vaccinia virus. In:  Binns MM,  Smith GL editor. Recombinant poxviruses. CRC Press; 1992;p. 235–267
  3. Casemore DP, Emslie ES, Whyler DK. Cowpox in a child, acquired from a cat. Clin. Exp. Dermatol. 1987;12:286–287
  4. CDC, 2001. Centers for Disease Control and Prevention. Vaccinia (smallpox) vaccination: recommendation of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal Wkly Rep. 2001;50 (RR-10):1–22.
  5. Henderson DA, Inglesby TV, Bartlett JG, et al.  Smallpox as biological weapon: medical and public health management. JAMA. 1999;281:2127–2137
  6. Kesson AM, Ferguson JK, Rawlinison SD, et al.  Progressive vaccinia treated with ribavirin and vaccinia immune globulin. Clin. Infect. Dis. 1997;25:911–914
  7. Klingebiel T, Vallbracht A, Dollar G, et al.  A severe human cowpox infection in south Germany. Pediatric Infect. Dis. J. 1988;7:883–885
  8. Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination : national survey in the United States. N. Engl. J. Med. 1969;281:1201–1208
  9. LeDuc JW, Jahrling PB. Strengthening national preparedness for smallpox: an update. Emerg. Infect. Dis. 2001;7:155–157
  10. Nakano JH, Esposito JJ. Poxviruses. In:  Schmidt NJ,  Emmons RW editor. Diagnostic procedures for Viral, Rickettsial, and Chlamydial infections. 6th ed.. Washington, DC: American Public Health Association; 1989;p. 224–265
  11. Neff JM. Vaccinia virus (cowpox). In:  Mandell GG,  Bennett JE,  Dolin R editor. Principles and practice of infectious diseases. 5th ed.. Churchill Livingston; 2000;p. 1553–1555
  12. Paoletti E. Applications of poxvirus vectors to vaccination: an update. Proc. Natl. Acad. Sci. USA. 1996;93:11349–11353
  13. Perry GF. Occupational medicine forum. J. Occupat. Med. 1992;34:757
  14. Wenzel RP, Nettleman MD. Smallpox vaccination for investigators using vaccinia recombinants. Lancet. 1989;2(8663):630–631
  15. Williams NR, Cooper BM. Counseling of workers handling vaccinia virus. Occup. Med. 1993;43:125–127

PII: S1386-6532(03)00118-5

doi: 10.1016/S1386-6532(03)00118-5

Journal of Clinical Virology
Volume 29, Issue 3 , Pages 167-170 , March 2004

Article Tools

* Image Usage & Resolution